Cargando…
Detection of Ca antigen in sera from normal individuals and patients with benign and malignant breast disease.
Two assay procedures, an inhibition radioimmunoassay (Inhibition-RIA) and an immunoradiometric assay (IRMA), were established for the detection of circulating tumour-associated Ca antigen. There was a good correlation between results (r = 0.987) but the Inhibition-RIA was selected for extended tests...
Autores principales: | Goodall, A. B., Evans, C. J., Trivedi, D., Coombes, R. C., Chantler, S. M. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1985
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977115/ https://www.ncbi.nlm.nih.gov/pubmed/2411281 |
Ejemplares similares
-
Measurement of prostate-specific antigen in detection of benign or malignant breast disease in women
por: Romppanen, J, et al.
Publicado: (1999) -
Tissue expression of the tumour associated antigen CA242 in benign and malignant pancreatic lesions. A comparison with CA 50 and CA 19-9.
por: Haglund, C., et al.
Publicado: (1989) -
Novel Molecular Markers of Malignancy in Histologically Normal and Benign Breast
por: Nasir, Aejaz, et al.
Publicado: (2011) -
Platelet sensitivity to prostacyclin in normal subjects, and in patients with benign and malignant tumours of the breast.
por: Benedetto, C., et al.
Publicado: (1985) -
Anti-Ia antibody in the sera of normal subjects after in vivo antigenic stimulation
Publicado: (1982)